Inhibition of tacrine oral clearance by cimetidine

被引:13
作者
Forgue, ST
Reece, PA
Sedman, AJ
deVries, TM
机构
[1] WARNER LAMBERT PARKE DAVIS,PHARMACEUT RES DIV,PHARMACOKINET DRUG METAB DEPT,ANN ARBOR,MI 48105
[2] WARNER LAMBERT PARKE DAVIS,PHARMACEUT RES DIV,DEPT CLIN PHARMACOL,ANN ARBOR,MI 48105
关键词
D O I
10.1016/S0009-9236(96)90114-9
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Plasma tacrine, 1-hydroxytacrine, 2-hydroxytacrine, and 4-hydroxytacrine concentrations were measured in 12 healthy elderly subjects in this nonblinded two-period study to assess the effect of multiple doses of cimetidine on single-dose tacrine pharmacokinetics, Subjects received 40 mg tacrine (Cognex) alone and during multiple dose cimetidine (300 mg four times a day) administration, Overall, tacrine and cimetidine were well tolerated by healthy elderly subjects, After coadministration of cimetidine with tacrine, plasma tacrine concentrations were approximately one-third higher than values after administration of tacrine alone; metabolite concentrations were also higher. Mean tacrine oral clearance was reduced by 30%; however, mean absorption rate and elimination half-lift values were not affected by cimetidine, It was concluded that cimetidine inhibits first-pass hepatic extraction of tacrine by cytochrome P450 enzymes but has little effect on systemic drug clearance, Clinical considerations may dictate a reduction in tacrine dosage when tacrine is coadministered with cimetidine.
引用
收藏
页码:444 / 449
页数:6
相关论文
共 30 条
[1]   PHARMACOKINETICS OF TETRAHYDROAMINOACRIDINE - RELATIONS TO CLINICAL AND BIOCHEMICAL EFFECTS IN ALZHEIMER PATIENTS [J].
AHLIN, A ;
ADEM, A ;
JUNTHE, T ;
OHMAN, G ;
NYBACK, H .
INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 1992, 7 (01) :29-36
[2]   THE EFFECT OF CIMETIDINE DOSE TIMING ON ORAL PROPRANOLOL KINETICS IN ADULTS [J].
ASGHARNEJAD, M ;
POWELL, JR ;
DONN, KH ;
DANIS, M .
JOURNAL OF CLINICAL PHARMACOLOGY, 1988, 28 (04) :339-343
[3]  
BROUWER KLR, 1992, APPL PHARMACOKINETIC
[4]   CIMETIDINE INTERACTION WITH AMITRIPTYLINE [J].
CURRY, SH ;
DEVANE, CL ;
WOLFE, MM .
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1985, 29 (04) :429-433
[5]  
CUTLER NR, 1990, PSYCHOPHARMACOL BULL, V26, P231
[6]  
De Vries T. M., 1993, Pharmaceutical Research (New York), V10, pS337
[7]   COMPARISON OF KINETIC INTERACTIONS OF NADOLOL AND PROPRANOLOL WITH CIMETIDINE [J].
DUCHIN, KL ;
STERN, MA ;
WILLARD, DA ;
MCKINSTRY, DN .
AMERICAN HEART JOURNAL, 1984, 108 (04) :1084-1086
[8]   PREVALENCE OF ALZHEIMERS-DISEASE IN A COMMUNITY POPULATION OF OLDER PERSONS - HIGHER THAN PREVIOUSLY REPORTED [J].
EVANS, DA ;
FUNKENSTEIN, H ;
ALBERT, MS ;
SCHERR, PA ;
COOK, NR ;
CHOWN, MJ ;
HEBERT, LE ;
HENNEKENS, CH ;
TAYLOR, JO .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1989, 262 (18) :2551-2556
[9]   A CONTROLLED TRIAL OF TACRINE IN ALZHEIMERS-DISEASE [J].
FARLOW, M ;
GRACON, SI ;
HERSHEY, LA ;
LEWIS, KW ;
SADOWSKY, CH ;
DOLANURENO, J .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1992, 268 (18) :2523-2529
[10]   PHARMACOKINETICS OF TACRINE HYDROCHLORIDE IN ALZHEIMERS-DISEASE [J].
FORSYTH, DR ;
WILCOCK, GK ;
MORGAN, RA ;
TRUMAN, CA ;
FORD, JM ;
ROBERTS, CJC .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1989, 46 (06) :634-641